Stay updated with breaking news from Roger Li. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
Study of CG0070 Given in Combination With Pembrolizumab, in Non-Muscle Invasive Bladder Cancer, Unresponsive to Bacillus Calmette-Guerin (CORE-001)
Roger Li, MD, discusses the rationale of the phase 3 MoonRISe-1 trial (NCT06319820).
Looking for a new job? We searched through local employment guides to curate a list of the best job openings around Pittsburgh this week.
HONG Kong is set to follow in the footsteps of the US by listing a batch of cryptocurrency exchange-traded funds, providing a window on whether the city is making progress on fashioning a hub for digital assets. Some of China’s top asset managers are in the final leg of preparations…
(Bloomberg) -- Hong Kong is set to follow in the footsteps of the US by listing a batch of cryptocurrency exchange-traded funds, providing a window on whether the city is making progress on fashioning a hub for digital assets.Most Read from BloombergTaylor Swift Is Proof That How We Critique Music Is BrokenTesla Stock in ‘No Man’s Land’ After 43% Rout Ahead of EarningsTech Giants Roar as Tesla Spikes in Late Hours: Markets WrapRay Dalio’s Famous Trade Is Sputtering, Investors BailingBillionaire